Cencora Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 2 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 397.09.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Cencora Inc is 6.93, ranking 122 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 85.93B, representing a year-over-year increase of 5.45%, while its net profit experienced a year-over-year increase of 14.54%.
Key Metrics
The current valuation score of Cencora Inc is 8.18, ranking 44 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 42.88, which is 9.00% below the recent high of 46.73 and 58.54% above the recent low of 17.78.
The current earnings forecast score of Cencora Inc is 8.33, ranking 43 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 397.50, with a high of 417.00 and a low of 279.21.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Cencora Inc is 9.42, ranking 6 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 374.26 and the support level at 336.12, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Cencora Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 94.90%, representing a quarter-over-quarter decrease of 0.20%. The largest institutional shareholder is The Vanguard, holding a total of 23.53M shares, representing 12.10% of shares outstanding, with 10.19% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Cencora Inc is 9.61, ranking 4 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.69. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Cencora Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
